Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies-Reference-Cited by-同舟云学术

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies

Published:2014-10-16 Issue:8 Volume:2019 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Acosta Angela¹²,Ciapponi Agustín³,Aaserud Morten⁴,Vietto Valeria⁵,Austvoll-Dahlgren Astrid⁶,Kösters Jan Peter⁷,Vacca Claudia⁸,Machado Manuel¹,Diaz Ayala Diana Hazbeydy¹,Oxman Andrew D⁹

Affiliation:

1. Universidad Nacional de Colombia; Departamento de Farmacia; Avenida Carrera 30 # 45, Bogotá, Cundinamarca Edificio Farmacia Bogota Bogota DC Colombia 111321

2. Universidad de Buenos Aires; Facultad de Medicina, Facultad de Farmacia y Bioquímica; Buenos Aires Argentina

3. Institute for Clinical Effectiveness and Health Policy (IECS-CONICET); Argentine Cochrane Centre; Dr. Emilio Ravignani 2024 Buenos Aires Capital Federal Argentina C1414CPV

4. Norwegian Medicines Agency; Statens legemiddelverk; Sven Oftedals vei 8 Oslo Norway NO-0950

5. Hospital Italiano de Buenos Aires; Family and Community Medicine Service; Buenos Aires Argentina

6. Norwegian Knowledge Centre for the Health Services; Postboks 7004 St. Olavsplass Oslo Norway 0130

7. Diakonhjemmet Sykehus; Medisinsk avd Oslo Norway 0370

8. Universidad Nacional de Colombia; Grupo RAM; Bogota Colombia

9. Norwegian Institute of Public Health; P.O. Box 4404, Nydalen Oslo Norway N-0403

Publisher

Wiley

Subject

Pharmacology (medical)

Reference94 articles.

1. The impact of generic drug competition on brand name market shares - evidence from micro data;Aronsson;Review of Industrial Organization,2001

2. Brekke K Grasdal A Holmås TH Steen F Sunnevåg K Evaluation of the new pharmacy act and the index price system Bergen (Norway): Rokkansenteret; 2003; Rapport 17 17406

3. Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment;Brekke;Journal of Public Economics,2011

4. Grootendorst P Dolovich L Holbrook A Levy A O'Brien B The impact of reference pricing of cardiovascular drugs on health care costs and health outcomes: evidence from British Columbia. Volume 2: Technical Report. SEDAP research paper no. 71 Hamilton (ON): McMaster University QSEP Report Series No. 370; 2002

5. Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs;Grootendorst;Canadian Medical Association Journal,2001

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Explaining why increases in generic use outpace decreases in brand name medicine use in multisource markets and the role of regulation;PLOS ONE;2024-05-02

2. Drug pricing and transparency in Europe and the United States: what is it and how does it work?;Expert Review of Pharmacoeconomics & Outcomes Research;2024-02

3. The impact of external reference pricing on pharmaceutical costs and market dynamics;Health Policy OPEN;2023-12

4. A systematic review of policies regulating or removing mark-ups in the pharmaceutical supply and distribution chain;Health Policy;2023-12

5. Physical-chemical repurposing of drugs. History of its formation in Russia;Reviews on Clinical Pharmacology and Drug Therapy;2023-10-10